Strides Pharma Science Ltd

NSE: STAR · BSE: 532531 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,103.30
Market cap: ₹10,169 Cr
Revenue (annual): ₹4,859 Cr
Net profit (annual): ₹556.2 Cr
P/E (TTM): 16.6×Sector 47.4×
Promoter holding: 27.91%+0.00% QoQ
FII holding: 28.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Sep 2026 21:47 IST BSE

Business Update

Strides Pharma Science Business Update

Strides Pharma Science received a Form 483 with three observations following a routine USFDA inspection at its Alathur formulations facility. The company will respond within stipulated timelines.

Read the filing ↗

19 Aug 2026 19:37 IST BSE

Business Update

Strides Pharma Science Business Update

Strides Pharma Science received a USFDA Establishment Inspection Report (EIR) for its Bengaluru facility. This confirms the successful closure of the recent cGMP inspection.

Read the filing ↗